Share Market News

Lupin, TPG, and EQT are considering buying Vitabiotics for £1 billion to grow in the nutraceutical market. This deal could change Lupin’s global presence, but valuation, integration, and regulations pose risks.

India's Trent stock dropped 40-45% in 2025 on slowing growth and margin pressure—but is this a warning sign or a buying opportunity? Read more to find out.

Meesho’s IPO opens on December 3 with a price band of ₹105-111, targeting a valuation of nearly $6 billion. The issue combines a fresh fundraise for technology and marketing with an Offer for Sale by early backers.

Oil prices fell as hopes of a ceasefire in Ukraine reduced the war-risk premium, while rising US crude inventories signalled near-term oversupply. The decline may influence inflation, corporate margins, sector rotations, and future market flows as traders watch OPEC+ and inventory data closely.

Zydus Lifesciences has entered into an exclusive agreement with US-based RK Pharma to license and commercialise a new sterile injectable supportive care product for the US market. RK Pharma will manufacture the product while Zydus will manage submission and launch, with filing expected in 2026. The companies estimate a market size of 6.2 million units.

Crude oil prices hovered near 1-month lows as progress in Ukraine peace talks tempered geopolitical risk premiums and raised expectations of sanction relief on Russian supply. Benchmarks saw mild rebounds supported by hopes of a US Federal Reserve rate cut, though weak demand signals and oversupply pressures limited upward momentum.

Gold prices surged considerably on Nov 25. The prices were driven by strong wedding season demand and rising expectations of a US Federal Reserve rate cut. With 24K gold crossing ₹1.25 lakh per 10 grams in major cities (Mumbai, Bangalore, New Delhi Hyderabad and Chennai), market volatility remains high.

The US has proposed a draft peace plan for the Russia-Ukraine war, easing global risk sentiment. Oil and commodity prices dipped, equity futures firmed, and India may see lower import costs, softer inflation, sector rotation, and shifting investor flows as talks progress.